Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

275
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
275
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

609
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
609
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

8.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.1K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

1.3K
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.3K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

55
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
55
Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

694
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
694

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data.

Journal of chemical information and modeling·2026
Same author

What Does a Model Really Look at?: Extracting Model-Oriented Concepts for Explaining Deep Neural Networks.

IEEE transactions on pattern analysis and machine intelligence·2024
Same author

Uncovering local aggregated air quality index with smartphone captured images leveraging efficient deep convolutional neural network.

Scientific reports·2024
Same author

An Interpretable Framework for Identifying Cerebral Microbleeds and Alzheimer's Disease Severity using Multimodal Data.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2023
Same author

Mask-Transformer-Based Networks for Teeth Segmentation in Panoramic Radiographs.

Bioengineering (Basel, Switzerland)·2023
Same author

Efficient mutation screening for cervical cancers from circulating tumor DNA in blood.

BMC cancer·2020

Related Experiment Video

Updated: Mar 20, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.7K

CADGL: Context-Aware Deep Graph Learning for Predicting Drug-Drug Interactions.

Azmine Toushik Wasi, Taki Hasan Rafi, Raima Islam

    IEEE Transactions on Computational Biology and Bioinformatics
    |March 18, 2026
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces CADGL, a novel framework for predicting drug-drug interactions (DDIs) using deep graph learning. CADGL enhances drug development by accurately identifying clinically valuable novel DDIs.

    More Related Videos

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.7K
    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    1.8K

    Related Experiment Videos

    Last Updated: Mar 20, 2026

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.7K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.7K
    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
    05:47

    Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

    Published on: June 13, 2025

    1.8K

    Area of Science:

    • Pharmacology
    • Computational Chemistry
    • Bioinformatics

    Background:

    • Drug-drug interactions (DDIs) are critical in drug development, influencing drug efficacy and safety.
    • Current DDI prediction models struggle with generalization, feature extraction, and real-world applicability.
    • Accurate DDI detection can accelerate the development of novel therapeutics.

    Purpose of the Study:

    • To address limitations in existing DDI prediction models.
    • To introduce a novel framework, CADGL, for improved DDI detection.
    • To leverage context-aware deep graph learning for robust feature extraction.

    Main Methods:

    • Developed CADGL, a framework based on a customized variational graph autoencoder (VGAE).
    • Employed two context pre-processors for feature extraction from local neighborhood and molecular contexts.
    • Utilized a heterogeneous graphical structure to capture critical information.

    Main Results:

    • CADGL demonstrated superior performance compared to state-of-the-art DDI prediction models.
    • The framework excelled in predicting clinically significant novel drug-drug interactions.
    • Case studies validated the model's effectiveness and potential for practical application.

    Conclusions:

    • CADGL offers a promising approach to overcome challenges in DDI prediction.
    • The framework's ability to capture structural and physio-chemical information enhances prediction accuracy.
    • CADGL has the potential to significantly advance drug discovery and development through improved DDI identification.